Lv32
268 积分 2025-12-23 加入
Human HDAC6 senses valine abundancy to regulate DNA damage
24天前
已完结
Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections
2个月前
已完结
Drug-resistant Acinetobacter baumannii : mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen
2个月前
已完结
‘Effectiveness of various sulbactam-based combination antibiotic therapy in the management of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in a tertiary care Health centre’
3个月前
已完结
Treatment efficacy of tigecycline in comparison to cefoperazone/ sulbactam alone or in combination therapy for carbapenenm-resistant Acinetobacter baumannii infections. DOI10.36721/PJPS.2020.33.1.REG.161-168.1
3个月前
已关闭
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience
3个月前
已完结
Cefiderocol-containing regimens versus best available therapy for carbapenem-resistant Acinetobacter infections
3个月前
已完结
[Clinical efficacy and safety of intravenous colistin sulfate monotherapy versus combination with nebulized inhalation for pulmonary infections caused by carbapenem-resistant gram-negative bacilli: a multicenter retrospective cohort study]
3个月前
已完结
Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia
3个月前
已完结
Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)
3个月前
已完结